申请人:Bayer Aktiengesellschaft
公开号:US05925645A1
公开(公告)日:1999-07-20
The 2-aryl-substituted pyridines are prepared by reacting pyridylaldehydes with organometallic compounds and then selectively reducing the products. The 2-aryl-substituted pyridines are suitable as active compounds in medicaments, in particular in medicaments for the treatment of arteriosclerosis.
2-芳基取代吡啶是通过将吡啶醛与有机金属化合物反应,然后选择性地还原产物制备的。2-芳基取代吡啶适用作为药物中的活性化合物,特别是用于治疗动脉硬化的药物。